NMBio MemberBioDirection, Inc
BioDirection is a start-up company defining the objective diagnosis of Traumatic Brain injury (concussion). BioDirection’s platform technology call Tbit™ is the world’s first low-cost portable point-of-care system to rapidly detect protein biomarkers linked to mild traumatic brain injury (concussion) from just a drop of blood.
The underlying Nanowire sensing technology, developed at Harvard University, enables rapid and simultaneous detection of multiple markers with ultra-high sensitivity and specificity. The technology is covered with a strong and broad patent portfolio.
Sergay Dryga, President
7317 Scagway Drive NE
Rio Rancho, NM 87144